<SEC-DOCUMENT>0000105770-15-000051.txt : 20151217
<SEC-HEADER>0000105770-15-000051.hdr.sgml : 20151217
<ACCEPTANCE-DATETIME>20151217112727
ACCESSION NUMBER:		0000105770-15-000051
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20151217
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151217
DATE AS OF CHANGE:		20151217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		151292690

	BUSINESS ADDRESS:	
		STREET 1:		101 GORDON DR
		STREET 2:		P O BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		101 GORDON DRIVE
		STREET 2:		PO BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8kdec172015.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>8-K</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s5ADC3D75CBA77A8D6AC0AB05AA9EFB49"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:4px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (Date of Earliest Event Reported) &#8211; December 17, 2015 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><img src="westlogo12172015.jpg" style="height:101px;width:252px;"></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="33%"></td><td width="4%"></td><td width="27%"></td><td width="4%"></td><td width="32%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pennsylvania</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-8036</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23-1210010</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of Incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530 Herman O. West Drive, Exton, PA</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19341-0645</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Registrant&#8217;s telephone number, including area code: </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">610-594-2900</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not Applicable</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former name or address, if changed since last report)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="5%"></td><td width="95%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="5%"></td><td width="95%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="5%"></td><td width="95%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="5%"></td><td width="95%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s5A7578A7214EBF088284AB05AACD23E8"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 5.02&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 17, 2015, West Pharmaceutical Services, Inc. (the "Company") announced that its Board of Directors formally appointed Chief Executive Officer Eric M. Green to the office of President of the Company. The appointment does not alter his responsibilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A copy of the press release issued by the Company is attached hereto as Exhibit 99.1 and is incorporated herein by reference.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01 Regulation FD Disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Also on December 17, 2015, the Company announced that the Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20, 2016. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in Item 7.01 of this report and Exhibit 99.1 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01 Other Events.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company announced a share repurchase program authorizing the repurchase of up to 700,000 shares of the Company's common stock from time to time on the open market or in privately negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions, but the program will commence on January 1, 2016 and is expected to be completed by December 31, 2016. The Company's previously authorized share repurchase program expires on December 31, 2015.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.16239316239316%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="11%"></td><td width="14%"></td><td width="75%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated December 17, 2015.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s251CFF7CD4005669236AAB05AAFCEA58"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.2991452991453%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="51%"></td><td width="49%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Federici</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Federici</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 17, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s87EEFF0EE74270288665AB05AB1BDE6C"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="13%"></td><td width="87%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated December 17, 2015.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh991pressreleasedec172015.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sAE08601B20FFA26ECD55AB05AA02A054"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;"><img src="exh991logo121715.jpg" style="height:53px;width:306px;"></div><div style="line-height:120%;text-align:left;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="51%"></td><td width="49%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Contacts:</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">West</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Michael A. Anderson</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Vice President and Treasurer</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(610) 594-3345</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Investors and Financial Media:</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Westwicke Partners</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">John Woolford</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(443) 213-0506</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">West Announces Quarterly Dividend and Share Repurchase Program</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Exton, PA December 17, 2015 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20, 2016.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company also announced a share repurchase program authorizing the repurchase of up to 700,000 shares of the Company&#8217;s common stock from time to time on the open market or in privately negotiated transactions as permitted under Securities Exchange Act of 1934 Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions, but the program will commence on January 1, 2016 and is expected to be completed by December 31, 2016. The Company&#8217;s previously authorized share repurchase program expires on December 31, 2015.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In addition, the Board of Directors formally appointed Chief Executive Officer Eric M. Green to the office of President of West Pharmaceutical Services, Inc.  The appointment does not alter his responsibilities. </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About West</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2014 sales of $1.42 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">West and the diamond logo and By your side for a healthier world&#8482; are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.</font></div><br><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exh991logo121715.jpg
<TEXT>
begin 644 exh991logo121715.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M5RX8I;6\9(\R5@K$#( "LQ(521?_ &D_VD_"7[)OP9UCQUXVU(:;H>CQY;:
MT]W*>([>%,CS)G;Y54=3UP 2/P1_;%_X*4Z;^W1\5H_$WQ"^&^J7UGI2R6^A
MZ3!XZELK;2+=R"V%6T<&:0)'YL@/S% !A5 'Q&493/&3NT^1;M6^Y7:_X![V
M,QD:"M?WGL1_M4_'SPS^WU\<KCQM\1OC-K.BR*C6NE:9:?#BXOK70;,L&%O"
M?[00L254R284R,H)  15P?#WP!_9QOW7^T/VE?%$ /4I\)KB''XF]EK%T_\
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MVN?T6#!0?2@X.:^?_P#@FK^VC:_MW?LJ:'XUVPVNN0L^F:]91/N%G?PX$@'
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MDD;>!='*LK!E8?9(^016.<PIT:,U"*UE:]EHN5/3L:824ISCS-[)[^;/!?\
M@NE^W)X^_9'\(?#30O .L6/A&Z^(6K3VE]XFNH1,ND00B'( *L%SY_F,^UF$
M=N^U23E=3_@G6_[4W@SXYWWA_P")7B'PU\7O@[J&D)J.D>/K*X@5I)WVF-(1
M&=TL;#S X8':1&RR%69:D_X+5?M&>#?@I\.?!>C_ !8^$,GQ"^$_BW64M=8U
ML:C]F_X16=2/*FC54,AN"C3&,K)%G:Z;\L%;Y#_X)(>,M'^'_P#P5CU7X?\
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MYH8VH.2^G_Z 05' =C-GG'E"OI#PO^S-_P % +/;]M_:*^%*[3R6\+?;,_\
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M67:!\@1/E#-)X>81R_+\)[-J,JEK+17;[O>W?\#OP\L3B*W-=J-^[MZ'SO\
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MY'EX'!\S]I4O9;)_\.%K:QV<"1PHL<<:A511M50.  .P [5-117Q)[@4444
M- R*Y#Q'\+E\0?$[0?$QO)(I-#BFB6V" K/Y@(R6SD8SVKKP, T@XJHR:=XF
M=2G":Y9K2Z?S3NA8EVQC/:G445)H-\I<Y]>M-^SJ/6I** &&'(I578*=10 T
MQAFH\E:=10%AHB 4CL::8%/K4E% #3$"*:(.?_KU)10%D-\I:/* S_G%.HH"
MQ'Y"@]Z#;CU:I** LAOE#%((0!^&*?10 P0+GO2^4-O?\Z=10%@4;13?*&2?
K6G44 ,$(!S2M'FG44 ,6$*:4Q9IU% #?)!-)Y"FGT4!9#438*=110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>westlogo12172015.jpg
<TEXT>
begin 644 westlogo12172015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !5 -(# 2(  A$! Q$!_\0
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MZYQ?3OM2@I/Y-V_%HZ,%C/J?"%2VCJS<5\[7_!,^'"<"OZ#_ /@W_P#V7O\
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M/^NIK@?@=\)M3_:'^-WA7P78/)-JGC#5[?31*3E@9I 'E)_V5+.3Z U]A_\
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MV-'\.+6[<>&_AI;1JT"-\DVHW$:RRRL.Y2-XXQGI\^/O&O$O^",_PQ?XJ_\
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M$OO@WX>\8>++?X:R_"FTUS6-8T[4-/-_*K37#RH"8Y@JA(5)P"W^L/TKNO\
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M(U7X-:W'X=\)2_VL8T-NEEIL]A>%A(APES)&Z1\9R6SD9'4UXC^SG^TMX/\
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M/]F_U-JI]O+C\P?]=C7X]_\ !5GQ%_PE'_!2+XT76[>$\3SVH/M"J0_^TZ^
MR;&_7>*<353O&G#D7RDK_C<_0,ZP7U'A;#TGI*I/G?S3M^%CQ%O%UZ?!:Z )
M"--6_.I&,?QS&)8@Q^B@@?[QKZ'_ ."07[+H_:P_;Z\$:)=6WVG0M"G/B+6
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
